TrialThe Lancet. Oncology2013

Prediction of late distant recurrence in patients with oestrogen-receptor-positive breast cancer: a prospective comparison of the breast-cancer index (BCI) assay, 21-gene recurrence score, and IHC4 in the TransATAC study population.

Dennis C Sgroi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.